{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:52:38Z","timestamp":1790607158024,"version":"4.1.0"},"reference-count":43,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.1536\/ihj.24-316","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:14:03Z","timestamp":1738275243000},"page":"74-80","source":"Crossref","is-referenced-by-count":4,"title":["A Randomized Controlled Study on the Clinical Efficacy of Ginkgo Biloba Combined with Nicorandil in Patients with HFmrEF"],"prefix":"10.1536","volume":"66","author":[{"given":"Xiang","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingding","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanliang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geratology, Weifang People&apos;s Hospital Affiliated with Shandong Second Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bloom MW, Greenberg B, Jaarsma T, <i>et al<\/i>. Heart failure with reduced ejection fraction. Nat Rev Dis Primers 2017; 3: 17058.","DOI":"10.1038\/nrdp.2017.58"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Murphy SP, Ibrahim NE, Januzzi JL. Heart failure with reduced ejection fraction: A review. JAMA 2020; 324: 488-504.","DOI":"10.1001\/jama.2020.10262"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. McDonagh TA, Metra M, Adamo M, <i>et al<\/i>. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021; 42: 3599-726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bozkurt B, Coats AJ, Tsutsui H, <i>et al<\/i>. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society, and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. J Card Fail 2021; 23: 352-80.","DOI":"10.1002\/ejhf.2115"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rubattu S, Sciarretta S, Volpe M. Atrial natriuretic peptide gene variants and their circulating levels: Implications in cardiovascular diseases. Clin Sci 2014; 127: 1-13.","DOI":"10.1042\/CS20130427"},{"key":"6","unstructured":"6. Li J, Cao JN, Liu WX, <i>et al<\/i>. Efficacy of sacubitril\/valsartan in treating chronic heart failure in elderly patients with dilated cardiomyopathy. Chin J Geriatr 2019; 38: 520-4."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shirakabe A, Hata N, Yokoyama S, <i>et al<\/i>. Efficacy and safety of nicorandil therapy in patients with acute heart failure. J Cardiol 2010; 56: 339-47.","DOI":"10.1016\/j.jjcc.2010.07.007"},{"key":"8","unstructured":"8. Zhao YP. Pharmacological research status of Ginkgo biloba leaf extract. Chin Med Guide 2010; 3: 44."},{"key":"9","unstructured":"9. Liu XP, Deng F. Effects of ginkgolide and ginkgolide on VEGF expression after cerebral ischemia-reperfusion injury in rats. J Stroke Neurol Dis 2015; 32: 108-12."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Xu LL, Hu ZY, Shen JJ, <i>et al<\/i>. Effects of Ginkgo biloba extract on cerebral oxygen adpglucose metabolism in elderly patients with pre-existing cerebralischemia. Complement Ther Med 2015; 23: 220-5.","DOI":"10.1016\/j.ctim.2014.12.009"},{"key":"11","unstructured":"11. Chen M, Luo HQ, Lu X, <i>et al<\/i>. The protective effect of ginkgolide on glutamatergic neurons in the midbrain of PD mice. Shi Zhen Natl Med Trad Chin Med 2013; 24: 614-7."},{"key":"12","unstructured":"12. Sun XH. Progress on the identification of active ingredients in Ginkgo biloba leaves. China Sci Technol Inform 2011; 4: 111."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891-975.","DOI":"10.1002\/ejhf.592"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sun XG, Hansen JE, Garatachea N, <i>et al<\/i>. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 2002; 166: 14438.","DOI":"10.1164\/rccm.2202033"},{"key":"15","unstructured":"15. Genth S, Zotz R, Darius H, <i>et al<\/i>. Comparison of the NYHA classification with cardiopulmonary function in patients with chronic heart failure. Z Kardiol 1996; 85: 428-34."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rickenbacher P, Kaufmann BA, Maeder MT, <i>et al<\/i>. Heart failure with midrange ejection fraction: A distinct clinical entity insight from a trial of intensified versus standard Medical therapy in elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017; 19: 1586-96.","DOI":"10.1002\/ejhf.798"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lund LH, Claggett B, Liu J, <i>et al<\/i>. Heart failure with midrange ejection fraction in CHARM: Characteristics, outcomes, and effects of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail 2018; 20: 1230-9.","DOI":"10.1002\/ejhf.1149"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. St\u00f6hr R, Brandenburg VM, Heine GH, <i>et al<\/i>. Limited role of fibroblast growth factor 23 in assessing prognosis in patients with heart failure: Data from the TIME-CHF trial. Eur J Heart Fail 2020; 22: 701-9.","DOI":"10.1002\/ejhf.1749"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Boulet J, Massie E, Rouleau JL. Heart failure with midrange ejection fraction: What is it, if anything? Can J Cardiol 2021; 37: 585-94.","DOI":"10.1016\/j.cjca.2020.11.013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Srivastava PK, Hsu JJ, Ziaeian B, <i>et al<\/i>. Heart failure with mid-range ejection fraction. Curr Heart Fail Rep 2020; 17: 1-8.","DOI":"10.1007\/s11897-019-00451-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cleland J, Bunting KV, Flather MD, <i>et al<\/i>. Betablockers for heart failure with reduced, midrange, and preserved ejection fraction: An individual patient-level analysis of doubleblind randomized trials. Eur Heart J 2018; 39: 2635.","DOI":"10.1093\/eurheartj\/ehx564"},{"key":"22","unstructured":"22. Deng CY, Dong MH, Sun SB, <i>et al<\/i>. Cardioprotective effect of neurandil against acute non-ST segment elevation myocardial infarction in the elderly. Chin J Gerontol 2014; 34: 3238-40."},{"key":"23","unstructured":"23. Li BL, Xiong XF, Zhu F, <i>et al<\/i>. Meta-analysis of the efficacy and safety of nicorandil in the treatment of heart failure. Chin J Evid Based Cardiovasc Med 2020; 12: 1425-31."},{"key":"24","unstructured":"24. Miao Z. <i>Meta-analysis of the Efficacy and Safety of Narcofloxacil in the Treatment of Patients with Ischemic Cardiomyopathy and Heart Failure<\/i>. Chengde Medical College; 2023."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Xu LL, Hu ZY, Shen JJ, <i>et al<\/i>. Effects of Ginkgo biloba extract on cerebral oxygen adpglucose metabolism in elderly patients with pre-existing cerebralischemia. Complement Ther Med 2015; 23: 220-5.","DOI":"10.1016\/j.ctim.2014.12.009"},{"key":"26","unstructured":"26. Wu F, Tian S, Xu T, <i>et al<\/i>. Clinical observation of Ginkgo biloba leaf drop medication for the treatment of chronic heart failure with depression. J Pract Trad Chin Med 2023; 39: 1118-20."},{"key":"27","unstructured":"27. Wei Y. Clinical observation of 60 patients with chronic congestive heart failure treated with metoprolol combined with Ginkgo biloba capsules. Chin J Clin N Med 2011; 4: 642-4."},{"key":"28","unstructured":"28. Ma JF, Liu XG, Zhao JH, <i>et al<\/i>. The effects of Qili Qiangxin capsules combined with nicorandil on cardiac function and cytokine levels in patients with ejection fraction preserved heart failure. Guangdong Med J 2023; 44: 379-82."},{"key":"29","unstructured":"29. Chen QQ, Wu XK, Dai HY, <i>et al<\/i>. Clinical observation of Ginkgo biloba leaf injection combined with trimetazidine for the treatment of chronic congestive heart failure. World J Integr Trad Chin West Med 2021; 16: 2285-8."},{"key":"30","unstructured":"30. He HJ, Xue SF. The efficacy of nicorandil combined with trimetazidine in the treatment of elderly patients with coronary heart disease and angina pectoris and its effects on inflammatory factors, endothelial damage, and blood lipids. Clin Res 2022; 30: 119-22."},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Su C, Yang C, Gong M, <i>et al<\/i>. Antidiabetic activity and potential mechanism of amentoflavone in diabetic mice. Molecules 2019; 24: 2184.","DOI":"10.3390\/molecules24112184"},{"key":"32","unstructured":"32. Li Q, Liu HM, Li LF. Progress in the study of common traditional Chinese medicines for the treatment of dyslipidemia. Chin J Atheroscler 2023; 31: 564-72."},{"key":"33","unstructured":"33. Wang X, Li A, Luo J, <i>et al<\/i>. Nicodil regulates glucose and lipid metabolism in diabetic rats via the PI3K\/AKT signaling pathway. Prog Anat Sci 2022; 28: 589-91."},{"key":"34","unstructured":"34. Cui BY. <i>Systematic Evaluation of the Efficacy of Ginkgo Biloba in the Treatment of Coronary Heart Disease with Diabetes and its Mechanism<\/i>. Beijing University of Traditional Chinese Medicine; 2021."},{"key":"35","unstructured":"35. Chen AM. Observation of the therapeutic effect of Irbesartan combined with Ginkgo biloba leaf drop therapy for the treatment of early chronic kidney disease. J Qiqihar Med College 2015; 36: 1762-3."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Tashiro Y, Yogo K, Serizawa K, <i>et al<\/i>. Nicorandil inhibits urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats. Clin Exp Nephrol 2015; 19: 343-9.","DOI":"10.1007\/s10157-014-0998-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tamura Y, Tanabe K, Kitagawa W, <i>et al<\/i>. Nicorandil, a K<sub>atp<\/sub> channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. Am J Physiol Renal Physiol 2012; 303: F339-49.","DOI":"10.1152\/ajprenal.00158.2012"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Sato T, Yoshihisa A, Kanno Y, <i>et al<\/i>. Cardiopulmonary exercise testing as a prognostic indicator: Comparisons among patients with heart failure with reduced midrange and preserved ejection fraction. Eur J Prev Cardiol 2017; 24: 197987.","DOI":"10.1177\/2047487317739079"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Magr\u00cc D, Piepoli M, Corr\u00c0 U, <i>et al<\/i>. Cardiovascular death risk in patients with recovered midrange ejection fraction heart failure: Insights from cardiopulmonary exercise test. J Card Fail 2020; 26: 932-43.","DOI":"10.1016\/j.cardfail.2020.04.021"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Alba AC, Adamson MW, MacIsaac J, <i>et al<\/i>. The added value of exercise variables on heart failure prognosis. J Card Fail 2016; 22: 492-7.","DOI":"10.1016\/j.cardfail.2016.01.012"},{"key":"41","unstructured":"41. Hursidam K. <i>A Study on the Effects of Home Exercise Rehabilitation Therapy (Mainly Focused on Walking) on Cardiac Function Parameters and Quality of Life in Patients with Stable Chronic Heart Failure<\/i>. Xinjiang Medical University; 2018."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Spertus JA, Jones PG. Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes 2015; 8: 469-76.","DOI":"10.1161\/CIRCOUTCOMES.115.001958"},{"key":"43","unstructured":"43. Gai XH, Liu SX, Ren T, <i>et al<\/i>. Progress on the chemical components, preparation types, and adverse reactions of Ginkgo biloba. Drug Evaluation Res 2017; 40: 742-51."}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/1\/66_24-316\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:13:15Z","timestamp":1738383195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/1\/66_24-316\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-316","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"24-316"}}